HANGZHOU, China - 28th May, 2026 - Hangzhou Thinheal Pharma-Tech Co., Ltd., a leading national high-tech enterprise specializing in peptide research, development, and manufacturing, is set to participate in FCE Pharma 2026 & FCE Cosmetique 2026, Latin America’s premier pharmaceutical and cosmetics industry trade show. The company will welcome partners, clients, and industry peers at Booth.No: I155 from June 1 to 3, 2026, at the São Paulo Expo Exhibition & Convention Center.
As a key player in the global peptide API market, Thinheal brings over 20 years of combined industry expertise in peptide drug development, cGMP-compliant production, and customized CDMO services to the Latin American market. The company’s participation in FCE Pharma 2026 underscores its commitment to expanding its footprint in the region and strengthening partnerships with pharmaceutical and biotech stakeholders across Brazil and beyond.
At Booth I155, attendees will have the opportunity to explore Thinheal’s comprehensive portfolio of high-quality peptide products, including GLP-1 analogs, Therapeutic Peptides, and research-grade materials, all manufactured under strict quality control standards to meet international regulatory requirements. The Thinheal team will also be available to discuss tailored solutions for peptide drug development, from lab-scale synthesis to commercial-scale production, as well as ongoing collaborations and distribution opportunities in Latin America.
“FCE Pharma is a pivotal platform for connecting with the Latin American pharma community, and we are eager to share our latest advancements in peptide technology with regional partners,” said a representative from Hangzhou Thinheal Pharma-Tech Co., Ltd. “We look forward to leveraging this event to foster new collaborations, address market needs, and support the growth of the Pharmaceutical Industry in Brazil and across Latin America.”
The São Paulo Expo Exhibition & Convention Center is located at Rodovia dos Imigrantes, 1.5km – Jabaquara, São Paulo-SP. For those planning to attend FCE Pharma 2026, Thinheal invites you to visit Booth I155 to learn more about the company’s products, capabilities, and partnership opportunities.
About Hangzhou Thinheal Pharma-Tech Co., Ltd.
Founded in 2019, Hangzhou Thinheal Pharma-Tech Co., Ltd. is a national high-tech enterprise dedicated to the research, development, production, and sales of peptide-based products. With a 2,000 sqm R&D center and multiple cGMP-compliant production lines, the company offers a full range of peptide industrialization services, including custom synthesis, API manufacturing, and CDMO solutions for clients worldwide. Thinheal’s products are exported to markets across North America, Europe, Asia, and Latin America, supporting the development of innovative therapies and research initiatives globally.
Media Contact
Company Name: Hangzhou ThinHeal Pharma-Tech Co., Ltd
Email: Send Email
Country: China
Website: https://www.thinhealpeptide.com/
